Ferrer Agiliza migration and synchronization of your data with informatica. through the integration of data from your CRM, ERP and BI, Ferrer systems get a greater return on their investment in data. Madrid, March 2012.-...
Read MoreMADRID, 9 (EUROPA PRESS) La Confederation of Spain scientific societies (COSCE) has drafted an open letter that shall deliver to the Prime Minister, Mariano Rajoy, and members of Congress and the Senate, to request an agreement...
Read MoreBerlin, 23 feb ( EFE).-the ecologist and Mexican researcher Gabriel Quadri of the Tower, candidate for the Presidency of the country by the party New Alliance, presented today at an international forum on climate change in...
Read More
Oral health for children How I help my children to care for their teeth and prevent cavities?...
Read MoreMADRID, 17 ( EUROPA PRESS) a report of the National Institute for excellence and health clinic of United Kingdom (NICE, its acronym in English) has determined that there is not enough scientific evidence that toxin botulinum or...
Read MoreKurú (French Guiana), 13 feb (EFE).-the new Vega rocket, the first spacecraft that launches the European aerospace industry in the 21st century, culminated today with success its risky maiden flight in one hour and 21 minutes,...
Read MoreKurú (French Guiana), 13 feb (EFE).-the new Vega rocket, the first spacecraft to that launches the European aerospace industry in the 21st century, culminated today with successful risky maiden flight at one hour and 21...
Read MoreGalChimia starts the process to be the first chemical company in Spain quoted in the MAB.
the Galician company aims to boost its internationalization process and enhance its capacity operational.
Santiago de Compostela, February 2012.- the Galician company GalChimia, a leader in Spain in services of synthetic organic chemistry oriented to the provision of advanced services to the pharmaceutical industry, has begun the process to quote in the market alternative investment market (aim).
GalChimia, headquartered in O Pino (A Coruña), will be the first Spanish company in the chemical industry listed in the MAB. The company announced its decision this morning, in the meeting of investors in the biotechnology cluster of Galicia (Bioga) in Santiago.
DCM Asesores will act as a consultant registered in the process, it intends to develop during the first half of the year. The company had also counselling goals BioTech, signature expert consulting services business to companies and investors in the life sciences sector.
With his departure to the MAB, the company will boost its internationalization process and will improve its operational capacity. GalChimia, founded in the year 2001, among others, by Carme PampÃn and James crosses, develops high value-added services for the chemical, pharmaceutical and biotechnology industries in Europe and United States.
GalChimia boasts a portfolio of more than one hundred customers in 25 countries, among the Almirall, Palau Pharma and Esteve, pharmaceutical and biotechnological Noscira, Midatech, GenMedica Therapeutics and Neuron BPH.
The path of steady growth of GalChimia in recent years has led to the decision to quote in the MAB company. Despite the economic crisis, their participation in national and international projects increasing has been increasing and, since its inception, the firm has become the most prominent example of business success in his sector.
the MAB is a stock market that operates with small capitalization companies seeking to expand. Listed companies put into value your business and improve their competitiveness, as well as bring new ways of financing, visibility to investors, liquidity and an objective assessment.
Galchimia, founded in the year 2001, is a leader in the Spanish market in synthetic organic chemistry processes. The company works with pharmaceutical companies in Europe, United States.UU. and Asia. Currently the company is intensifying the process of internationalisation.
Read More
The new socio-health centre of Calahorra pioneered thermal use of the subsoil to generate energy.
-the new Viamed our Lady Virgin of the Carmen de Calahorra socio-health centre will open its doors in 2012 with 75 beds capacity for chronic patients, elderly or long recovery
-Viamed group made an investment of 5.3 million euros in the construction of this new Centre which incorporates an innovative system of geothermal energy
– as part of the energy project of the CenterIt has designed a geothermal installation that will take advantage of the stable temperature of the soil to provide warmth in winter and cool in summer.
Calahorra, 2011-December The new Viamed our Lady Virgin of the Carmen de Calahorra socio-health center, which will open in 2012, will be pioneered the use of geothermal energy, from the stable temperature of the subsoil to generate energy to provide the new Center heat in summer and cold in winter.
The project aims to reduce the energy cost of the Centre through the use of geothermal permanently. The system has been developed and implemented by the GEOTER company, within the framework of the Geotcasa programme, promotion of geothermal energy that drives the IDAE (Institute for diversification and energy savings).
According to sources from the direction of the Centre, the geothermal project of Viamed to Calahorra relies on 25 110 m deep boreholes. Each one of them introduces two pipes of drive and two return are filled with water in order to create a circuit that allows to take advantage of the stable subsurface temperature.
The “geothermal response test” conducted on the ground have been validated capacity termofÃsica of the plot for a period of 25 years, for which the energy sustainability of the project is guaranteed.
About three kilometres of pipes under the ground be channelled in two collectors which communicated with the building, where the key element of the whole process will be installed: a geothermal pump that will take advantage of the stable temperature of the water from underground to generate heat in winter and cool in summer.
In addition, an extensive network of pipelines within the socio-health center channelled hot water, cooling and sanitary water. On the other hand, the provision of floor heating in the entire building will ensure an adequate air conditioning, additional installation geothermal to work in low temperature without radiators.
New Centre partner-sanitary in Calahorra
The new socio-health centre Viamed our Lady Virgin of Carmen of Calahorra La Rioja open in 2012, after an investment of more than EUR 5 million and will result in the creation of new 70 jobs.
With this new Centre Viamed will culminate the network of socio-health centres of the group in La Rioja, complementing those they already manages in Haro, Los Jasmine; and in Logroño, with the Valvanera clinic.
The new Center, located next to the Hospital Calahorra, will serve 75 patients requiring socio-health care; so it should not necessarily require hospital care, but that does require attention and care specific.
Group Viamed has 10 hospitals and partner health in all Spain, in La Rioja, Aragon, Andalusia, Murcia and Madrid; with over 1,000 beds and the creation of more than 2,000 jobs in recent years.
The private health care group is led by highly qualified professionals and with great experience and knowledge of the health care sector and management also boasts solvent funding, supported by some of the main investment deprived in the country.
The expansion of group Viamed has allowed to have in any Spain with surgical hospitals, hospitals of medium and long stay of internal medicine and Geriatrics, units of biomedical research and technology, Monográficas units of Alzheimer’s disease, socio-health centers for dependents, outpatient centers, transportation health and services.
Read More
accordingly, and because many people want to have beautiful teeth and a smile healthy, dentistry comes perfecting techniques and materials to realize the dream of an increasing number of people. “Before speaking on techniques for whitening and restorations of last generation, it is important to say that the teeth are stained or darkened to prevent the main causal factors so that the problem does not appear or increase”, says Rafael Mondelli, surgeon-dentist and professor of the Faculty of Dentistry of Bauru (USP).
the specialist, who will lead the Symposium on new dental whitening techniques during the 30° Congress of Dentistry of São Paulo, which happens between 28 and January 31, 2012 says that, with the exception of genetic causes, the consumption of some drugs and excess fluorine, a large part of the factors could be avoided. “It is important that people become more perfect in oral hygiene, stop smoking and eating some types of food and drink that can stain your teeth, such as coffee, black tea, red wine, oriental and curry sauce, for example.”
Mondelli asserts that, while until quite recently the restorations were made of gold, amalgam or any other material which left the smile with dark spots, today the indirect restorations of type inlays, onlays, veneers and blades – used to fill cavities and small or large spaces between your teeth – can be made in high quality or composite resinbetter yet, translucent porcelain and which approximates the natural color of the teeth of the patient. “One of the trends that are here to stay is the replacement of old restorations, stained and after dental bleaching, by imperceptible and restores that resemble the color and shape of the teeth of the person. With respect to the choice of materials, although there are sophisticated composite resins, porcelain systems offer better aesthetics, increased strength, color stability and durability. “
another trend highlighted by the surgeon-dentist is to preserve as much as possible the natural structure of the tooth. “From the moment that we use all available technology to save the patient’s tooth, we turned both to new restorations on more advanced techniques of dental bleaching. Even in the most difficult cases, where the bleaching is not sufficient to ensure a beautiful smile for a long time, or even when there are spaces between the teeth that compromise the aesthetics, not giving the purpose of preserving the patient’s natural tooth. In these situations, you can rely on the porcelain blades which provide minimum wear dental and are fixed to the surface of the teeth, with excellent aesthetics and patient acceptance. “
according to Rafael Mondelli, in your quest for the perfect smile and in more extreme cases, you can choose by dental implants which today are much more accessible in terms of investment and less traumatic for patients. In some specific situations also can opt for gingival plastic, resulting in a more youthful appearance to so many people who have the gingival smile high. “Today, aesthetic dentistry offers numerous options of treatments for those who are unhappy with your smile. In addition, as the surgeons-dentists Brazilians are among the best in the world, the investment is worth. Just use a professional well recommended. “
Source: Press
/> Page
Read More
The perfumes are an object of desire for women. A rich perfume is irresistible for us, so it worth spending money on them, is a real investment. Every woman has her taste especially in perfumes some love the floral, other the more sweet or citrus, there are a variety of brands and aromas to choose. The imported perfumes are the best quality, also packaging designs are beautiful, its duration is increased to others, even if its price is high.
the smell of a perfume is the final touch to any look and distinguishes us from the rest of the people that is so important for women. In the market there are a lot of brands of perfumes to choose from with different aromas and according to every taste and age. Every year appear new perfumes that had joined other classics that are manufactured for decades such as Chanel 5 which remains in force. But 3 perfumes used by women and sold worldwide this year are Be delicious for women DKNY, Flora Gucci, 212 by Carolina Herrera. Millions of bottles of these perfumes are sold in different countries are a success.
These perfumes are a common feature that adapt to all kind of woman that managed to soaring sales. These fragrances are different but mark the personality of the woman who uses and enhance the femininity of each. Its aromas are really beautiful and bring sophistication and distinction to any look that we carry. These 3 perfumes are really highly recommended, choose any of them to be used because they are excellent and can be used for any occasion you want us to feel more attractive. There are many other perfumes that are so well excellent so must try several to then choose which use. It is always advisable to have a fragrance for everyday use and one for special occasions. Perfumes is called the second skin that is so important to find a scent that makes us feel really good and keep it in time
Read More
Acquires Menarini group Invida.
Singapore, Florence, November 2011- Singapore, Australia, China, Hong Kong, India, Indonesia, Malaysia, New Zealand, Korea South, Taiwan, Thailand, Philippines and Viet Nam. These are the countries which opens the Italian multinational headquartered in Florencia, Menarini group, following the signing in Singapore of the contract for Invida Group Private Limited (Invida), until now in the hands of Temased Holding (a company of Asian investment Singapore-based), Quintiles (North American biotechnology and pharmacy services company) and Zuelling (leader in distribution of health in Asia).
Invida group is one of the major pharmaceutical companies with activity in the Asia Pacific region, an area which represents 10% of the global pharmaceutical market, and has a 20% annual growth. With a turnover of more than 220 million dollars (160 million euros) annually, it employs 3,500 people in template and a consolidated presence in major therapeutic areas. Invida to Menarini represents the most suitable company for your opening emerging countries with the highest rates of growth in the world. The financial terms of the transaction have not been revealed.
Development model provided by Menarini for group Invida provides, as in all purchases above, assess the identity, culture and local competences, and thus ensures Invida and its human resources based on a highly entrepreneurial vision future, dynamic and not speculative.
“ Has been a challenging negotiations to which we have worked in full in recent months ” said Alberto Giovanni Aleotti, together with the director general Piero Corsa has guided the negotiating team of Menarini. Also on this occasion our team has worked with extraordinary passion, and I take this opportunity to thank each Member of the same heart ”. For Aleotti: “ Singapore perceives the vitality of all the countries of the area and focus the best skills, thanks to policies with a vision for the future of the Governments of the area ”.
“ En Invida have found the Menarini of Asia, and a management with exceptional powers ”, discussed Piero Corsa and Domenico Simone, CEOs of Menarini, underlining the potential of the acquisition: “ have a headquarters in Singapore is ideal to create a bridge between Europe and Asia and to Asian patients carry that way all the therapeutic benefits of our medicines ”.
John Graham, CEO of Invida to continue conducting activities in the Asia Pacific area.
Lucia Aleotti, Vice-President of the Menarini group has concluded: “ this challenge we are excited about, because one side puts us before great opportunities for expansion in rapidly developing countries, and on the other hand, our group will bring new highly qualified ”.
About Menarini
Menarini group is the leading Italian pharmaceutical group in the world, settling in the 15th place of 4.881 European companies and ranked 34 of 14.051 companies in the world by turnover, according to data from 2010. Last year the company invoiced 3,031 million euros. The company employs 12.890 workers, of which 91% are graduates and technical specialists. Menarini group has always pursued two strategic objectives: research and internationalization. both targets have enabled Menarini results highlighted in the global market; as well as reinvested in research and innovation of new drugs, making them available to patients around the world.
With a presence in over 100 countries, Menarini group is responsible for the needs of patients and specialist health care in the following therapeutic areas: cardiovascular, Gastroenterology, antibiotics, in the respiratory field, products for the treatment of diabetes, anti-inflammatory drugs and analgesics.
On group Invida
Invida improves the lives of the patients in Asia through the marketing of prescription drugs and pharmaceutical advertising specialties (EFP). As a result of this acquisition, all shareholders will grow with the company. All this has been a careful plan of brand marketing and a know-how applied to sales, combined with extensive experience in therapeutic areas key and deep knowledge of the Asian market.
About 3,500 employees in 13 Asia-Pacific markets, Invida operates throughout the production chain from regulatory to launch the product approval through the management of the life of the drug. Manages a broad participation in other brands of products approved, from small to large biotech companies and health multinational. Partnering is the key to the business model of Invida. It works closely with partners, to develop effective strategies and putting his extensive experience as a backup to maximize the assets entrusted to them.
Read More
